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1. Introduction
  Irritable bowel syndrome (IBS) is a common intestinal 
disorder characterized by persistent or intermittent 
abdominal pain or discomfort,distention,and changes 
in stool pattern. It has been became a serious health 
problem that affacts an estimated 2.9%-15.6% of people 
in Asian countries nowadays[1]. IBS is associated with 
abnormal intestinal motion and sensations,intestinal 
infection,hypothalamic-pituitary-gut axis dysregulation. 
Recently, a growing number of findings proved that immune 
activation play a majoy role in the pathophysiology of IBS[2]. 
The intestinal mucosa contains numerous DCs, which can 
mediate the innate and the adaptive immune system[3,4].  
  Transforming growth factor-毬1  (TGF-毬1) belongs to a 
well-defined multipotent cytokine family known to regulate 
several pathophysiological events and exhibit the broadest 
spectrum of biological activities. Runt-related transcription 
factor 3 (Runx 3) is a novel tumor-suppressor gene,it 
involved in the differentiation of immune cells[5], especially 
the each step of T-cell differentiation[6]. As a part of the 
innate immune response, Runx3, TGF-毬1 and dendriti 
cells have been postulated to participate in mucosal and 
systemic immune responses in many studies,but the 
relationship of them have not been reported. The aim of this 
study was to evaluate the expression levels and correlations 
among the expressions of TGF-毬1, Runx3 and CD83 in 
colonic mucosal specimens from IBS patients.
2.  Materials and methods
2.1.  Subjects and specimens
  A total of 40 patients were selected,who were confirmed as 
IBS by Rome III standard and were admitted from March to 
December, 2013 at the clinic of digestive diseases, Hainan 
Provincial People’s Hospital (Haikou, China). All patients 
were evaluated by colonic-rectum endoscopy and showed 
normal colonic tissue. Meanwhile, 40 healthy volunteers 
were selected as control. Colonic mucosal specimens of 
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each subject were collected from colon sigmoideum with 
biopsy forceps and specimens were preserved in stored at 
-80 曟immediately for subsequent RNA extraction.
2.2. Real-time PCR
  Total RNA was isolated from colonic tissue using the 
RNeasy Micro Kit (Qiagen, Santa Clarita, CA), reverse 
transcription was performed using the Power RT Kit cDNA 
(Bio TeKe, Beijing, China) according to the manufacturer’s 
protocols. Real-time PCR was performed to measure 
expression levels of target mRNAs using a 2伊SYBR realtime 
RT-PCR premixture (Bio TeKe, Beijing, China). Briefly, the 
reactions were incubated at 95 曟 for 2 min, followed by 45 
cycles of denaturation at 95 曟 for 15 s, annealing at 60 曟 for 
60 s in ABI PRISM 7300 Sequence Detection System Ther-
mal Cycler(Applied Biosystems). Oligonucleotides (Table 1) 
were designed by Primer 5 software and synthesised at the 
Sangon Biotech (Shanghai, China).
Table 1
Primers in this study.
Primers Primer or probe sequence (5′to 3′)
Runx3 Forward: GACTGTGATGGCAGGCAATGA
Reverse:  CGAAGCGAAGGTCGTTGAA
TGF-毬1 Forward:  GGGACTATCCACCTGCAAGA
Reverse:  CCACCCGGTCGCGGGTGCTGT
CD83 Forward:  TCCATCCTCTCTTCACCACC
Reverse:  CTGTGCCCACCATATTCC
GAPDH Forward:  TTTGGTATCGTGGAAGGACTC
Reverse:  GTAGAGGCAGGGATGATGTTCT
2.3.  Statistical analysis
  Statistical analysis was performed using SPSS software 
version 17.0. Results are reported as means依SD Student’s 
t-test was used to compare Runx3, TGF-毬1 and CD83 
mRNA levels between the IBS and control group. 
Correlations between two data sets were assessed using 
Persons correlation test. P-values of <0.05 were considered 
significant.
3. Results
3.1. Runx3, TGF-毬1 and CD83 mRNA expressions in 
sigmoid colon tissue from IBS patients
  Compared with the control group, CD83 mRNA expressions 
were higher in patients with IBS than in healthy controls 
(P<0.05) (Figure 1). However , there was no significance in 
colonic mRNA expressions of Runx 3 (P>0.05) and TGF-毬1 
(P>0.05) when compared with the control group. 
3.2. Correlations among mRNA expressions of TGF-毬1, 
Runx3 and CD83
  CD83 mRNA expressions were associated with Runx3 
mRNA levels (r=-0.361, P<0.05). Meanwhile, Runx3 mRNA 
levels were associated with TGF-毬1 mRNA expressions 
in IBS patients (r=0.402, P<0.05) (Figure 2). But there is no 










Control group                                 IBS group
Figure 1. Runx3, TGF-毬1 and CD83 mRNA expressions in sigmoid 
colon tissue from IBS patients. 
Compared with the control group, CD83 mRNA expressions were 
higher in patients with IBS than in healthy controls (P<0.05). 
However, there was no significance in colonic mRNA expressions 
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Figure 2. Correlations among mRNA expressions of TGF-毬1, Runx3 
and CD83. 
CD83 mRNA expressions were associated with Runx3 mRNA levels 
(r=-0.361, P<0.05). Meanwhile, Runx3 mRNA levels were associated 
with TGF-毬1 mRNA expressions in IBS patients (r=0.402, P<0.05). 
But there is no correlation between the mRNA expressions of TGF-毬
1 and CD83 (P>0.05). 
4. Discussion
  IBS is a functional gastrointestinal disorder characterized 
by abdominal pain and altered bowel habits in the absence 
of specific and unique organic pathology. Its pathophysiology 
is still not entirely clear.Emerging evidence revealed that 
inflammation play a crucial role in the occurrence and 
development of IBS[7,8].
  Dendritic cells (DCs) are key regulators in the immune 
system. DCs are found in two functionally distinct states: 
immature and mature dendritic cells. Immature DCs are 
present in peripheral tissues and are mainly phagocytic 
cells. Mature DCs are specialized antigen presentation cells 
that orchestrate innate and adaptive immune responses, 
they can act by priming abnormal T cell responses to the 
enteric flora in organized lymphoid tissues. Sustain DCs 
reactivity within the inflamed mucosa via the release 
of proinflammatory cytokines, for example, mature DCs 
expressing higher levels of costimulatory molecules (CD40, 
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CD80, and CD86) and increased amounts of IL-12p40 and 
IL-23p19 upon CD40 ligation[9]. While IL-12p40 and IL-
23p19 can form IL-23, which is important for the growth 
and stabilization of Th17 cells in the mouse and their 
differentiation in humans[10], while Th17 cell differentiation 
can adrive inflammation. DCs play an important role in the 
occurrence and development of intestinal disease. Several 
observations suggest that DCs may play a pathogenic role 
in humans and in mouse models of inflammatory bowel 
diseases (IBDs), including Crohn disease and ulcerative 
colitis, are chronic relapsing inflammatory diseases of the 
gastrointestinal tract. Murakami et al[11] showed an increase 
of mucosal CD83+ and CD86+ cells producing macrophage 
inhibitory factor, which is thought to contribute to neutrophil 
recruitment and activation in ulcerative colitis. Cremon 
et al[12] demonstrated that the magnitude of the immune 
infiltrate detected in patients with IBS was markedly lower 
than that of active or quiescent ulcerative colitis in some 
comparative studies, this may imply that DCs also plays a 
role in intestinal inflammation in IBS patients. 
  Some research shows that TGF-毬1 can inhibit the 
maturation of DC. TGF-毬1 plays an important role in 
mediating the balance of the inflammation responses 
within the intestinal mucosa. Notably, TGF-毬1 promotes 
early dendritic cells’ development in vitro and suppresses 
immature dendritic cells’ activation and maturation[13]. 
For exampled treated with TGF-毬1 in vitro become less 
responsive to maturation stimuli such as IL-1毬 and TNF-
毩[14], thereby reducing the efficacy of dendritic cells to 
stimulate T lymphocytes. 
  The mammalian RUNX3 gene resides on human 
chromosome 1p36.1 and mouse chromosome 4 respectively. 
It belongs to the RUNX family of transcription factors, which 
contains three genes. In mice, Sugai et al[5] found that the 
loss of Runx3 in T cells resulted in suppression of Treg 
cell function which lead to the development of colitis in 
Runx3-/- animals. 
  Runx3 is highly expressed in DCs, where its functions 
as a component of TGF-毬 signaling cascade[15]. Runx3 
KO DCs do not respond to TGF-毬, their maturation is 
accelerated and accompanied by an increase defficacy to 
stimulate T cells,the abnormal DCs function constitute a 
primary immune system defect associated with spontaneous 
development of lung inflammation in the KO mice[15].
  Similar to the result of our previous study on rat model 
with IBS, the colonic level of Runx3 mRNA and TGF-毬1 
mRNA did not show any remarkable changes in IBS group 
compared with their control group. This negative data may 
be result from the clinic type of IBS, the lasting time of 
the inflammation and the depth of the samples. But the 
expression of CD83 mRNA was higher than the control group, 
which indicates the maturation of dendritic cells maybe a 
important role in IBS patients.
  Interestingly, in IBS patients, there is a significant 
correlation between Runx3 mRNA and TGF-毬1, suggesting 
that Runx3 - TGF-毬1  inflammation pathway might be 
involved in human IBS. Runx3 mRNA and CD83 mRNA 
also have certain correlation, but there is no correlation 
between TGF-毬1 mRNA and Runx3 mRNA,this may imply 
that Runx3 may regulate the maturation of dendritic cells 
through other signal transduction system in IBS patients.
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